We need to move on from missed opportunities. Focus on where we are today. I'm glad they didn't raise $20 million. That would have been overly dilutive. By the time we get an outcome there will probably be 600 million SOI. That's pretty good compared to peers. PAA is in a very good position with a promising drug emerging just when other treatments fail or underperform. It's a big category, neurodegenerative disease. The FDA has been generous in its treatment of our applications. ODD granted and preliminary approval considered. We may only be a year away from 24 week results. So Buckland while I like the negative balance you bring to this forum, I have to disagree with your outlook.
Ann: PharmAust Presentation, page-68
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.005(3.13%) |
Mkt cap ! $80.22M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.5¢ | 16.5¢ | $276.1K | 1.636M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 379426 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |